AR and prostate carcinoma: It has been reported that in response to a physiological concentration of metabolically stable androgen (R1881), the small VCP/p97-interacting protein (SVIP) expression could be down-regulated by AR on a transcriptional level in prostate cancer cell line LNCaP [16]; however, the phenomenon has not been established on a protein level till date.